SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-085803
Filing Date
2023-03-30
Accepted
2023-03-30 17:30:50
Documents
2
Group Members
A. RACHEL LEHENYERIC W. ROBERTSVALENCE INVESTMENTS SPV IV, LLCVALENCE INVESTMENTS SPV V, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d486014dsc13d.htm SC 13D 132986
2 EX-99.A d486014dex99a.htm EX-99.A 8719
  Complete submission text file 0001193125-23-085803.txt   143594
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Subject) CIK: 0001534133 (see all company filings)

IRS No.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91725 | Film No.: 23781978
SIC: 2834 Pharmaceutical Preparations

Mailing Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 212-521-4379
Valence Investments SPV VI, LLC (Filed by) CIK: 0001971787 (see all company filings)

IRS No.: 000000000
Type: SC 13D